(PR-inside.com) Research and Markets ( http://www.researchandmarkets.com/re...ple_analysis_c : http://cts.businesswire.com/ct/CT?id...166499846f4946 ) has announced the addition of the " Triple Analysis: Colorectal Cancer, Protein Kinase Inhibitors and Peptides : http://cts.businesswire.com/ct/CT?id...96171de10905c4 " report to their offering.This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Colorectal Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area (Peptides). Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer ..
More...
More...